OREX
Orexigen Therapeutics, Inc.
OREX
OREX
Delisted
OREX was delisted on the 3rd of April, 2018.
160 hedge funds and large institutions have $843M invested in Orexigen Therapeutics, Inc. in 2015 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 57 increasing their positions, 41 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
9% more funds holding
Funds holding: 147 → 160 (+13)
35% less call options, than puts
Call options by funds: $11.9M | Put options by funds: $18.1M
Holders
160
Holding in Top 10
5
Calls
$11.9M
Puts
$18.1M
Top Buyers
| 1 | +$16M | |
| 2 | +$10.2M | |
| 3 | +$9.29M | |
| 4 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$8.81M |
| 5 |
TCM
Tamarack Capital Management
Carlsbad,
California
|
+$7.83M |
Top Sellers
| 1 | -$20M | |
| 2 | -$18M | |
| 3 | -$14.7M | |
| 4 |
LCP
Lamond Capital Partners
San Francisco,
California
|
-$11.5M |
| 5 |
JP Morgan Chase
New York
|
-$4.44M |